ask="32.00"
ask_size="400"
average_daily_volume="221042"
bid="20.15"
bid_size="100"
book_value="3.79"
change="-0.65"
change_from_200_day_moving_average="4.32"
change_from_50_day_moving_average="2.00"
change_from_52_week_high="-2.77"
change_From_52_week_low="16.36"
change_in_percent="-2.09%"
close="30.48"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.07"
ebitda="-37.24M"
eps_estimate_current_year="-2.36"
eps_estimate_next_quarter="-0.54"
eps_estimate_next_year="-2.97"
ex_dividend_date="N/A"
float_shares="15981000"
high="31.14"
high_52_weeks="33.25"
last_trade_date="3/14/2017"
last_trade_price="30.48"
last_trade_size="2728"
last_trade_time="4:00pm"
low="29.89"
low_52_weeks="14.12"
market_capitalization="653.25M"
moving_average_200_day="26.16"
moving_average_50_day="28.48"
name="Aclaris Therapeutics
Inc."
notes="N/A"
one_year_target_price="26.33"
open="31.09"
pe_ratio="N/A"
peg_ratio="-0.22"
percent_change_from_200_day_moving_average="+16.51%"
percent_change_from_50_day_moving_average="+7.04%"
percent_change_from_52_week_high="-8.33%"
percent_change_from_52_week_low="+115.86%"
previous_close="31.13"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="8.22"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21432000"
short_ratio="7.75"
stock_exchange="NMS"
symbol="ACRS"
volume="90153"
weeks_range_52="14.12 - 33.25"
